by Usha Govindarajulu | Nov 23, 2022 | Biostatistics, Blog, COVID-19, Healtcare, Usha Govindarajulu
Issues in COVID-19 research and statistical analyses (Part XVVXVVIV) November 23, 2022 In an article from November 11, 2022 in Health News from NPR, Rob Stein lays out the likelihood of two new Omicron subvariants, BQ.1 and BQ.11 of SARS-Cov-2 having become dominant...
by Usha Govindarajulu | Nov 9, 2022 | Biostatistics, Blog, COVID-19, Healtcare, Usha Govindarajulu
November 9, 2022 In a recent article from November 1 in Science Immunology, the authors reported on their analysis of T-cell immunity four weeks and six months after different vaccination regimens and four weeks after an additional booster vaccination. This was a...
by Usha Govindarajulu | Oct 14, 2022 | Biostatistics, Blog, COVID-19, Healtcare
October 13, 2022 A recent article in JAMA, “Association of Primary and Booster Vaccination and Prior Infection With SARS-CoV-2 Infection and Severe COVID-19 Outcomes” focuses on looking at the association of COVID-19 vaccination and boosters or prior infection with...
by Usha Govindarajulu | Dec 22, 2021 | Biostatistics, Blog, COVID-19, Usha Govindarajulu
The new variant of COVID-19, Omicron, and boosters from vaccines has been receiving a lot of press. In an article published in BMJ on December 14, 2021, “Covid-19: Omicron and the need for boosters”, the authors take us through a detailed summary about how a booster...
by Usha Govindarajulu | Oct 29, 2021 | Biostatistics, Blog, Usha Govindarajulu
Mix and match boosters October 27, 2021 In recent news, the CDC/FDA are approving booster shots not only for Pfizerã but also for Modernaã and Johnson & Johnsonã, and even mixing and matching these boosters, but is there any science behind this...
